Understanding end-tidal CO2 monitoring
This noninvasive technique gives early warning of respiratory compromise.
Technology
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous leukemia. Synribo…
Quiz Time
A goal of the induction phase of therapeutic hypothermia after cardiac arrest is to: a. quickly warm the patient to target body temperature. b.…
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing patients with…
Recent advances in cardiac diagnostic and surgical procedures
New techniques expand the options for high-risk patients and cause fewer complications than conventional surgery.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome negative (Ph-)…
IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures Acceleration Network—Workshop…
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage breast…
FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps gauge the…
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating delivery volume…
Understanding end-tidal CO2 monitoring
This noninvasive technique gives early warning of respiratory compromise.
FDA approves Synribo for chronic myelogenous leukemia
On Oct. 26, the U.S. Food and Drug Administration (FDA) approved Synribo (omacetaxine mepesuccinate) for the treatment of adults with chronic myelogenous…
Quiz Time
A goal of the induction phase of therapeutic hypothermia after cardiac arrest is to: a. quickly warm the patient to target body…
New report on how mobile devices are transforming health care
May’s Issues in Technology Innovation includes the report “How Mobile Devices are Transforming Healthcare,” which includes a review of techniques for managing…
Recent advances in cardiac diagnostic and surgical procedures
New techniques expand the options for high-risk patients and cause fewer complications than conventional surgery.
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…
FDA approves Marqibo for rare type of leukemia
On Aug. 9, the U.S. Food and Drug Administration (FDA) approved Marqibo (vincristine sulfate liposome injection) to treat adults with Philadelphia chromosome…
IOM releases report on accelerating new drug and diagnostics development
On Aug. 22, the Institute of Medicine released “Accelerating the development of new drugs and diagnostics: Maximizing the impact of the Cures…
Using evidence-based practice to develop a swallow screen for stroke patients
The author takes the reader on her step-by-step journey that resulted in a change in practice.
FDA approves Perjeta for late-stage breast cancer
On June 8, the U.S. Food and Drug Administration (FDA) approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive…
FDA approves DNA test to help manage CMV infection in organ transplant patients
On July 5, the U.S. Food and Drug Administration approved COBAS AmpliPrep/COBAS TaqMan CMV Test, a DNA viral load test that helps…
New needle-free jet injection device offers improvement over similar devices
Researchers at MIT have developed a needle-free injection device to deliver drugs. The device offers greater control than previous devices for regulating…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.